SCHEMBL30847716

SCHEMBL30847716

CC(C)(C)OC(=O)N1CCC(c2ccc3c(c2)NC(=O)C3(C)C)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
THRB P10828 1/20 0.52
DDB1 Q16531 2/20 0.50
CRBN Q96SW2 2/20 0.50
NAMPT P43490 1/20 0.47
PDE4B Q07343 1/20 0.46
GPR119 Q8TDV5 4/20 0.43
HRH3 Q9Y5N1 2/20 0.43
HTT P42858 1/20 0.43
P2RY14 Q15391 1/20 0.43
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41
WNT3A P56704 1/20 0.41
IGF1R P08069 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30847579 0.91 KDM4E (0.52) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL30847508 0.89 MAPT (0.47) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL27371173 0.87 KDM4E (0.48) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL27371219 0.86 KDM4E (0.47) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL25036594 0.83 KDM4E (0.50) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL16366870 0.83 KDM4E (0.50) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL30273494 0.83 KDM4E (0.50) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL2885375 0.82 CRBN (0.52) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL30847462 0.82 KDM4E (0.47) KDM4EMAPTTHRBDDB1CRBN
SCHEMBL30847534 0.82 KDM4E (0.47) KDM4EMAPTTHRBDDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024192064-A1 COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 DEGRADERS AND USES THEREOF ONCOPIA THERAPEUTICS, INC. D/B/A/ PROTEOVANT THERAPEUTICS, INC. (US) 2024-09-19 WO disclosed
WO-2024064316-A1 COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 INHIBITORS AND USES THEREOF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-03-28 WO disclosed